Cargando…

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis

Systemic mastocytosis (SM) is a hematologic neoplasm with abnormal accumulation of mast cells in various organ systems such as the bone marrow, other visceral organs and skin. So far, only little is known about epigenetic changes contributing to the pathogenesis of SM. In the current article, we pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reszka, Edyta, Jabłońska, Ewa, Wieczorek, Edyta, Valent, Peter, Arock, Michel, Nilsson, Gunnar, Nedoszytko, Bogusław, Niedoszytko, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999363/ https://www.ncbi.nlm.nih.gov/pubmed/33803981 http://dx.doi.org/10.3390/ijms22062964

Ejemplares similares

DNA methylation profile in patients with indolent systemic mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2021)

Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy
por: Niedoszytko, Marek, et al.
Publicado: (2021)

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
por: Brockow, Knut, et al.
Publicado: (2021)

A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
por: Romantowski, Jan, et al.
Publicado: (2021)

Association of mastocytosis with interleukin 31 gene polymorphism
por: Nedoszytko, Boguslaw, et al.
Publicado: (2015)

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2021)

Genetic and Epigenetic Aspects of Atopic Dermatitis
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

The role of the clinical and psychological symptoms of mastocytosis in the patient’s quality of life
por: Spolak-Bobryk, Natalia, et al.
Publicado: (2021)

Assessing quality of life in patients with mastocytosis: development of the disease-specific questionnaire
por: Spolak-Bobryk, Natalia, et al.
Publicado: (2022)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review
por: Wieczorek, Edyta, et al.
Publicado: (2014)

Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
por: Valent, Peter, et al.
Publicado: (2020)

Disruptions of Circadian Genes in Cutaneous Melanoma—An In Silico Analysis of Transcriptome Databases
por: Lesicka, Monika, et al.
Publicado: (2023)

Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
por: Valent, Peter, et al.
Publicado: (2022)

Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis
por: Lyberg, Katarina, et al.
Publicado: (2016)

Therapeutic Potential of Selenium and Selenium Compounds in Cervical Cancer
por: Jablonska, Ewa, et al.
Publicado: (2021)

Effect of Arsenic Exposure on NRF2-KEAP1 Pathway and Epigenetic Modification
por: Janasik, Beata, et al.
Publicado: (2017)

-2518A/G polymorphism of monocyte chemotactic protein 1 (MCP-1/CCL2) is associated with cutaneous mastocytosis
por: Ługowska-Umer, Hanna, et al.
Publicado: (2022)

Modulation of dermal equivalent of hypothalamus-pituitary-adrenal axis in mastocytosis
por: Antoniewicz, Jakub, et al.
Publicado: (2021)

The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2016)

Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO Subgroups
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle‐shaped mast cells in bone marrow
por: Spolak‐Bobryk, Natalia, et al.
Publicado: (2022)

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
por: Lange, Magdalena, et al.
Publicado: (2021)

Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients
por: Reszka, Edyta, et al.
Publicado: (2014)

Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2023)

Dysregulation of Redox Status in Urinary Bladder Cancer Patients
por: Reszka, Edyta, et al.
Publicado: (2020)

New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood
por: CZARNY, Justyna, et al.
Publicado: (2020)

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
por: Valent, Peter, et al.
Publicado: (2020)

Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches
por: Valent, Peter, et al.
Publicado: (2019)

Altered circadian genes expression in breast cancer tissue according to the clinical characteristics
por: Lesicka, Monika, et al.
Publicado: (2018)

Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility
por: Lesicka, Monika, et al.
Publicado: (2019)

Mastocytosis in children and adults: clinical disease heterogeneity
por: Lange, Magdalena, et al.
Publicado: (2012)

Relevance of selenoprotein transcripts for selenium status in humans
por: Reszka, Edyta, et al.
Publicado: (2011)

Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis
por: Atiakshin, Dmitri, et al.
Publicado: (2021)

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
por: Schneeweiss, Mathias, et al.
Publicado: (2018)

The Effect of Selenium Supplementation on Glucose Homeostasis and the Expression of Genes Related to Glucose Metabolism
por: Jablonska, Ewa, et al.
Publicado: (2016)

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
por: Lyberg, Katarina, et al.
Publicado: (2022)

Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond
por: Sprinzl, Bettina, et al.
Publicado: (2021)

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
por: Arock, Michel, et al.
Publicado: (2018)

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
por: Peter, Barbara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_866f6d5ail4o1cf4mr9hsgesue